Affiliation:
1. The National Kidney Foundation Singapore, Singapo
Abstract
The prevalence of end-stage kidney disease (ESKD) in Singapore remains high and continues to rise. We
continue to face major challenges in containing the rising incidence of ESKD and providing sustainable kidney
replacement therapy. Our cost projections provide an insight into the present and future, urging a call to action
to augment existing initiatives to address the emergent issues.
Keywords: End-stage kidney disease, health economics, peritoneal dialysis, kidney replacement therapy,
sustainable costs
Publisher
Academy of Medicine, Singapore
Reference17 articles.
1. National Registry of Diseases Office. Singapore Renal Registry Annual Report 2019, 30 July 2021. Available at: https://www.nrdo. gov.sg/docs/librariesprovider3/default-document-library/srr-annual-report-2019.pdf?sfvrsn=8822fcf8_0. Accessed on 13 December 2021.
2. Phan TP, Alkema L, Tai ES, et al. Forecasting the burden of type 2 diabetes in Singapore using a demographic epidemiological model of Singapore. BMJ Open Diabetes Res Care 2014;2:e000012.
3. Wong LY, Liew AST, Weng WT, et al. Projecting the burden of chronic kidney disease in a developed country and its implications on public health. Int J Nephrol 2018;2018:5196285.
4. Lim GJ, Liu YL, Low S, et al. Medical costs associated with severity of chronic kidney disease in type 2 diabetes mellitus in Singapore. Ann Acad Med Singap 2020;49:731-41.
5. National Organ Transplant Unit. Live On Resources, 30 June 2021. Available at: https://www.liveon.gov.sg/docs/info_booklets/LiveOn_ stats.pdf. Accessed on 13 December 2021.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献